Identification of Eligible Studies
Guillermo Delgado-García Division of Neurology, National Institute of Neurology and Neurosurgery, Mexico City, Mexico
We read with great interest the meta-analysis recently published by Lee and Song [1] in the Journal of Rheumatic Diseases. According to the authors, this meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [1] . PRISMA is an evidence-based minimum set of items for reporting in systematic reviews and meta-analyses. Eligibility criteria are the sixth item of the PRISMA checklist. Carefully defined eligibility criteria inform various steps of the review methodology. They influence the development of the search strategy and serve to ensure that studies are selected in a systematic and unbiased manner [2] . Language restriction and inclusion (or not) of grey literature (e.g., abstracts) are part of the eligibility criteria, and they can influence the effect estimates in meta-analyses [2] .
In February 2015, we reported our findings on this topic at the XLIII Mexican Congress of Rheumatology, which later appeared as abstracts in a supplement of Reumatología Clínica [3] [4] [5] , the official publication of the Spanish Society of Rheumatology and the Mexican College of Rheumatology. We included 36 adult lupus patients with inactive disease (Mexican version of the Systemic Lupus Erythematosus Disease Activity Index [Mex-SLEDAI]) and 56 healthy controls. Our results are shown in Table 1 . In general, our findings are consistent with those reported in this meta-analysis. However, in a subsequent study, we found no evidence of association between neutrophil to lymphocyte ratio and Mex-SLEDAI [6] .
